Exploring the protective effects of flavonoids on eye diseases that cause blindness
Novel neuroprotective activities of flavonoids against retinal degenerative diseases
This study is looking at how a natural compound called quercetin might help protect your eyesight by stabilizing important proteins in the eye, with the hope of finding new treatments for people with retinitis pigmentosa, a condition that can lead to blindness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11091571 on NIH RePORTER |
What this research studies
This research investigates how flavonoids, particularly quercetin, can protect against retinal degenerative diseases like retinitis pigmentosa (RP), which leads to blindness. The study will evaluate the effectiveness of quercetin in stabilizing mutated rhodopsin proteins that are crucial for vision. Researchers will conduct experiments both in laboratory settings and in mouse models to assess how these compounds can improve retinal health and potentially reverse the effects of RP. The goal is to identify safe and effective treatments for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with retinitis pigmentosa or other retinal degenerative diseases.
Not a fit: Patients with retinal conditions unrelated to rhodopsin mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for patients with retinitis pigmentosa, potentially preserving or restoring vision.
How similar studies have performed: Previous studies have shown promising results with flavonoids in ocular health, suggesting potential for success in this novel approach.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Jastrzebska, Beata — Case Western Reserve University
- Study coordinator: Jastrzebska, Beata
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.